Strides Arcolab gives India business a boost by acquiring portfolio of drugs from Sun Pharma

Strides Arcolab gives India business a boost by acquiring portfolio of drugs from Sun Pharma

Shares of Stride Arcolab gained 4.6% on Monday after the firm announced over the weekend that it was paying Rs.165 crore to acquire a portfolio of drugs from Sun Pharmaceutical Industries.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter